Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells

Abstract

Genistein, a natural isoflavonoid found in soybean products, has been proposed to be associated with a lower rate of breast cancer in Asian women. Studies from our laboratory and others have shown that genistein can induce apoptosis by regulating the expression of apoptosis-related genes in breast cancer cells. However, the precise molecular mechanism(s) by which genistein induces apoptotic cell death is not clear. In order to investigate such mechanism, we tested the role of Akt and NF-κB in genistein-treated MDA-MB-231 breast cancer cells. We found that inhibition of cell growth and induction of apoptosis by genistein are partly mediated through the downregulation of Akt and NF-κB pathways. Gel shift assay showed that NF-κB DNA-binding activity in MDA-MB-231 cells transfected with Akt cDNA was induced, suggesting that there is a cross-talk between NF-κB and Akt signaling pathway. Moreover, we found that genistein could abrogate EGF and Akt induced NF-κB activation. From these results, we conclude that the inactivation of NF-κB by genistein in MDA-MB-231 breast cancer cells is partly mediated via Akt pathway, which could be useful for rational design of strategies for the prevention and/or treatment of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fukami Y . (1987). J. Biol. Chem., 262, 5592–5595.

  • Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA . (1996). EMBO J., 15, 6541–6551.

  • Alhasan SA, Pietrasczkiwicz H, Alonso MD, Ensley J and Sarkar FH . (1999). Nutr. Cancer, 34, 12–19.

  • Arias AM, Brown AM and Brennan K . (1999). Curr. Opin. Genet. Dev., 9, 447–454.

  • Beg AA, Sha WC, Bronson RT, Ghosh S and Baltimore D . (1995). Nature, 376, 167–170.

  • Bharti AC and Aggarwal BB . (2002). Biochem. Pharmacol., 64, 883–888.

  • Bijur GN, De Sarno P and Jope RS . (2000). J. Biol. Chem., 275, 7583–7590.

  • Blume-Jensen P and Hunter T . (2001). Nature, 411, 355–365.

  • Bradlow HL and Sepkovic DW . (2002). Ann. N. Y. Acad. Sci., 963, 247–267.

  • Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF and Mabry TJ . (2002). J. Nutr., 132, 3482S–3489S.

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME . (1999). Cell, 96, 857–868.

  • Buell P . (1973). J. Natl. Cancer Inst., 51, 1479–1483.

  • Chen L, Fischle W, Verdin E and Greene WC . (2001). Science, 293, 1653–1657.

  • Chen ZJ, Parent L and Maniatis T . (1996). Cell, 84, 853–862.

  • Constantinou A, Kiguchi K and Huberman E . (1990). Cancer Res., 50, 2618–2624.

  • Dale TC . (1998). Biochem. J., 329 (Part 2), 209–223.

  • Davis JN, Singh B, Bhuiyan M and Sarkar FH . (1998). Nutr. Cancer, 32, 123–131.

  • Diehl JA, Cheng M, Roussel MF and Sherr CJ . (1998). Genes Dev., 12, 3499–3511.

  • Downward J . (1998). Curr. Opin. Cell Biol., 10, 262–267.

  • Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R and Schweigerer L . (1995). J. Nutr., 125, 790S–797S.

  • Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R and Schweigerer L . (1997). Cancer Res., 57, 2916–2921.

  • Gray GE, Pike MC and Henderson BE . (1979). Br. J. Cancer, 39, 1–7.

  • Grilli M, Chiu JJ and Lenardo MJ . (1993). Int. Rev. Cytol., 143, 1–62.

  • Hirayama T . (1978). Prev. Med., 7, 173–195.

  • Kane LP, Shapiro VS, Stokoe D and Weiss A . (1999). Curr. Biol., 9, 601–604.

  • Lamartiniere CA, Moore J, Holland M and Barnes S . (1995). Proc. Soc. Exp. Biol. Med., 208, 120–123.

  • Li Y, Bhuiyan M and Sarkar FH . (1999a). Int. J. Oncol., 15, 525–533.

  • Li Y and Sarkar FH . (2002). Clin. Cancer Res., 8, 2369–2377.

  • Li Y, Upadhyay S, Bhuiyan M and Sarkar FH . (1999b). Oncogene, 18, 3166–3172.

  • Lian F, Bhuiyan M, Li YW, Wall N, Kraut M and Sarkar FH . (1998). Nutr. Cancer, 31, 184–191.

  • Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E and Slingerland JM . (2002). Nat. Med., 8, 1153–1160.

  • Meng F, Liu L, Chin PC and D'Mello SR . (2002). J. Biol. Chem., 277, 29674–29680.

  • Miller AB . (1977). Cancer, 39, 2704–2708.

  • Orford K, Crockett C, Jensen JP, Weissman AM and Byers SW . (1997). J. Biol. Chem., 272, 24735–24738.

  • Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB . (1999). Nature, 401, 82–85.

  • Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM and Sellers WR . (1999). Proc. Natl. Acad. Sci. USA, 96, 2110–2115.

  • Romashkova JA and Makarov SS . (1999). Nature, 401, 86–90.

  • Santibanez JF, Quintanilla M and Martinez J . (2000). Nutr. Cancer, 37, 49–54.

  • Shao ZM, Wu J, Shen ZZ and Barsky SH . (1998). Cancer Res., 58, 4851–4857.

  • Sharma M, Chuang WW and Sun Z . (2002). J. Biol. Chem., 277, 30935–30941.

  • Sizemore N, Leung S and Stark GR . (1999). Mol. Cell Biol., 19, 4798–4805.

  • Spinozzi F, Pagliacci MC, Migliorati G, Moraca R, Grignani F, Riccardi C and Nicoletti I . (1994). Leuk. Res., 18, 431–439.

  • Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM . (1996). Science, 274, 787–789.

  • Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A and Santoro M . (2002). Nat. Med., 8, 1136–1144.

  • Wang CY, Guttridge DC, Mayo MW and Baldwin Jr AS . (1999). Mol. Cell Biol., 19, 5923–5929.

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS . (1998). Science, 281, 1680–1683.

  • Wei H, Wei L, Frenkel K, Bowen R and Barnes S . (1993). Nutr. Cancer, 20, 1–12.

  • Zhou BP, Liao Y, Xia W, Spohn B, Lee MH and Hung MC . (2001a). Nat. Cell Biol., 3, 245–252.

  • Zhou BP, Liao Y, Xia W, Zou Y, Spohn B and Hung MC . (2001b). Nat. Cell Biol., 3, 973–982.

Download references

Acknowledgements

This work was partly funded by a grant from the National Cancer Institute, NIH (CA83695-O1A2 awarded to FHS) and was also supported by an unrestricted grant from the RGK foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fazlul H Sarkar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gong, L., Li, Y., Nedeljkovic-Kurepa, A. et al. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22, 4702–4709 (2003). https://doi.org/10.1038/sj.onc.1206583

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206583

Keywords

This article is cited by

Search

Quick links